Topical preparation | Brand name (United States) | Usual dosage (adult)* | Corticosteroid | pH | Preservative | Notes |
Acidifying/antiseptic solution | ||||||
Acetic acid 2% otic solution | Generic (formerly Acetasol) | 3 to 5 drops four to six times daily | None | 3.5 to 5 | No additional |
|
Acidifying/antiseptic and corticosteroid combination | ||||||
Acetic acid 2% and hydrocortisone 1% otic solution | Acetasol HC | 4 to 6 drops three or four times daily | Hydrocortisone | 2 to 4 | No additional |
|
Antibiotic and corticosteroid combinations | ||||||
Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension | Ciprodex | 4 drops twice daily | Dexamethasone | Buffered | Benzalkonium chloride |
|
Ciprofloxacin 0.2% and hydrocortisone 1% otic suspension | Cipro HC | 3 drops twice daily | Hydrocortisone | Buffered | Benzyl alcohol |
|
Neomycin, polymyxin B, and hydrocortisone otic suspension (each mL contains 3.5 mg neomycin, 10,000 units polymyxin B, and 10 mg hydrocortisone) | Generic (formerly Cortisporin otic) | 4 drops three or four times daily | Hydrocortisone | Acidic | Potassium metabisulfite |
|
Neomycin 0.33%, colistin 0.3%, and hydrocortisone 1% otic suspension | Cortisporin-TC | 5 drops three or four times daily | Hydrocortisone | 5 | Thimerosal |
|
Tobramycin 0.3% and dexamethasone 0.1% ophthalmic suspensionΔ | TobraDex | 4 drops three or four times daily | Dexamethasone | Buffered | Benzalkonium chloride |
|
Antibiotic | ||||||
Solutions | ||||||
Ciprofloxacin 0.2% otic solution | Cetraxal | 0.25 mL twice daily | None | Buffered | None; single-use container |
|
Ofloxacin 0.3% otic solution | Generic (formerly Floxin otic) | 10 drops once daily | None | 6.5 | Benzalkonium chloride |
|
Health care provider-administered suspension | ||||||
Ciprofloxacin 6% otic suspension | Otiprio | 0.2 mL as a single dose | None | Buffered | None; single-use container |
|
TM: tympanic membrane.
* Daily dose administered in affected ear; to enhance delivery, patients should be educated on proper administration.
¶ In patients with a suspected or confirmed nonintact TM, avoid nonsterile and ototoxic preparations (ie, containing aminoglycosides or alcohol) as well as acidic preparations as they may reach the middle ear and cause worsening symptoms, pain, and loss of hearing.
Δ Available only as ophthalmic preparation but can be applied directly to the ear to treat acute external otitis.Data from: Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.
Additional data from:آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟